Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversies in ventricular remodelling.

Lionel H Opie1, Patrick J Commerford, Bernard J Gersh

  • 1Hatter Institute for Heart Research, Cape Heart Centre and Department of Medicine, University of Cape Town Faculty of Health Sciences, Observatory 7925, Cape Town, South Africa. Opie@capeheart.uct.ac.za

Lancet (London, England)
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Journal of the American Heart Association·2018
Same author

Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis.

The international journal of cardiovascular imaging·2018
Same author

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

Journal of the American College of Cardiology·2018
Same author

High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.

Circulation·2018
Same author

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.

Heart (British Cardiac Society)·2018
Same author

The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist.

Mayo Clinic proceedings·2018
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Ventricular remodelling involves structural changes in the heart

Area of Science:

  • Cardiovascular biology and pathology.
  • Cardiac remodeling mechanisms.
  • Heart failure pathophysiology.

Background:

  • Ventricular remodeling encompasses structural changes in the left ventricle due to chronic alterations in loading conditions.
  • Key patterns include concentric remodeling (pressure load), eccentric hypertrophy (volume load), and myocardial infarction.
  • The adaptive versus maladaptive nature of left-ventricular hypertrophy remains debated, with implications from aortic stenosis and signaling pathways.

Purpose of the Study:

  • To review the pathophysiology of ventricular remodeling and the transition to heart failure.
  • To discuss emerging and novel therapeutic strategies targeting these complex processes.

Main Methods:

  • Review of existing literature on ventricular remodeling, hypertrophy, and heart failure.

Related Experiment Videos

  • Discussion of potential therapeutic interventions based on mechanistic insights.

    • Main Results:

    • The transition to heart failure involves complex interactions of metalloproteinases, reactive oxygen species, and neurohumoral factors.
    • Several novel therapeutic avenues are proposed, including pharmacological agents, surgical interventions, and cell-based therapies.

    Conclusions:

    • Ventricular remodeling is a dynamic process with critical implications for heart failure development.
    • Novel therapeutic strategies targeting specific molecular pathways and mechanical interventions offer potential for managing heart failure.